
---
title: '儿童肝炎病因扑朔迷离，又一国家通告5天8例，肝炎概念股六天五板，股价创新高，散户大本营霸榜，下周63股面临解禁（附股）'
categories: 
 - 金融
 - 证券时报网
 - 数据
headimg: 'https://data.stcn.com/djsj/202205/W020220507289701793605.png'
author: 证券时报网
comments: false
date: Sat, 07 May 2022 07:59:00 GMT
thumbnail: 'https://data.stcn.com/djsj/202205/W020220507289701793605.png'
---

<div>   
<p>根据世卫组织5月3日公布的官方数据，截至5月1日，全球范围内至少有228名儿童报告了不明原因的急性肝炎，确诊病例分布国家达到20个。在过去一周，出现病例的国家增加了8个。</p><p>据央视新闻报道，当地时间5日，阿根廷卫生部发布通告称，过去短短5天，阿根廷境内已发现8例不明原因儿童肝炎病例。通告称，8名小患者分属不同地区且相互之间不存在任何关联性。截至目前，医学界尚未找到这种新肝炎的病因。世卫组织和美国疾病预防控制中心表示，不排除是一种新病毒导致这种肝炎的发生。</p><p>A股方面，昨日肝炎概念股<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ002693" code="002693">双成药业</a>开盘一字跌停，随后打开跌停，下午14点39分左右，股价直线爆拉并于14点44分封住涨停直至收盘，戏剧性上演“地天板”一幕。</p><p style="text-align: center;"><img src="https://data.stcn.com/djsj/202205/W020220507289701793605.png" title="WechatIMG156.jpeg" alt="WechatIMG156.jpeg" width="500px" height="642.3076923076924px" style="width: 500px; height: 642.308px;" oldsrc="W020220507289701793605.png" referrerpolicy="no-referrer"></p><p>公司近6个交易日录得5个涨停板，股价创下历史新高。龙虎榜资金昨日净买入3514.31万元。“散户大本营”之称的<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ300059" code="300059">东方财富</a>证券拉萨营业部霸榜，位列买五，卖二、卖三、卖四席位。肝炎概念股中，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ002644" code="002644">佛慈制药</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS600056" code="600056">中国医药</a>和<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ002864" code="002864">盘龙药业</a>昨日同样涨停。</p><p style="text-align: center;"><img src="https://data.stcn.com/djsj/202205/W020220507289701831359.png" title="WechatIMG157.jpeg" alt="WechatIMG157.jpeg" width="500px" height="926.9230769230769px" style="width: 500px; height: 926.923px;" oldsrc="W020220507289701831359.png" referrerpolicy="no-referrer"></p><p>证券时报·数据宝统计，今年以来，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS600056" code="600056">中国医药</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS603229" code="603229">奥翔药业</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ002864" code="002864">盘龙药业</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ300158" code="300158">振东制药</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ002550" code="002550">千红制药</a>的股价累计上涨幅度均超20%，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS600056" code="600056">中国医药</a>以116.77%的累计上涨幅度居首。</p><p><a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ300676" code="300676">华大基因</a>近日在官方微信公众号宣布，已紧急研制并提供腺病毒41型核酸检测及PMseq病原联合筛查方案，助力不明原因儿童急性肝炎快速筛查。</p><p>4月以来，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ300601" code="300601">康泰生物</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ300529" code="300529">健帆生物</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS600056" code="600056">中国医药</a>、振东医药、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ300676" code="300676">华大基因</a>获得北上资金加仓，其中<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ300601" code="300601">康泰生物</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ300529" code="300529">健帆生物</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS600056" code="600056">中国医药</a>的累计净买入均超亿元。</p><p>25只肝炎概念股在一季度中均实现盈利，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS688575" code="688575">亚辉龙</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ300601" code="300601">康泰生物</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ002550" code="002550">千红制药</a>的一季度业绩同比翻倍增长。</p><p>对于今年全年的业绩情况，机构一致预测<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS688575" code="688575">亚辉龙</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ300009" code="300009">安科生物</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS688278" code="688278">特宝生物</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ300049" code="300049">福瑞股份</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS603229" code="603229">奥翔药业</a>的2022年全年净利润同比大幅增长（增幅大于50%），其中<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS688575" code="688575">亚辉龙</a>和<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ300009" code="300009">安科生物</a>有望分别增长433.1%和225.39%。</p><p>平安证券认为，我国是全球肝病负担最重的国家，拥有乙肝病毒（HBV）携带者9000万人，丙肝病毒（HCV）携带者1000万人，鉴于肝病具有大量未被满足的治疗需求，创新药的市场空间值得期待。</p><p style="text-align: center;"><img src="https://data.stcn.com/djsj/202205/W020220507289701891264.png" title="WechatIMG664.png" alt="WechatIMG664.png" width="500px" height="365.5514250309789px" style="width: 500px; height: 365.551px;" oldsrc="W020220507289701891264.png" referrerpolicy="no-referrer"></p><p><strong>63股面临解禁</strong></p><p>下周将有63只股解禁，按照最新收盘价计算，合计解禁市值793.75亿元。其中<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS603259" code="603259">药明康德</a>分别将在5月9日和12日解禁16.66万股和378.61万股。</p><p><a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ000301" code="000301">东方盛虹</a>解禁市值最大，下周将有27.68亿股上市流通，主要是定向增发机构配售股份，解禁市值达339.11亿元。<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS600906" code="600906">财达证券</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ000019" code="000019">深粮控股</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ300223" code="300223">北京君正</a>的解禁市值居前。</p><p><a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ000835" code="000835">长动退</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ300512" code="300512">中亚股份</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ300642" code="300642">透景生命</a>的解禁压力较小，解禁市值均不足千万元。</p><p>从解禁股数量占总股本的比例来看，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS603697" code="603697">有友食品</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ002953" code="002953">日丰股份</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ000019" code="000019">深粮控股</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ300778" code="300778">新城市</a>的解禁比例均超过50%。</p><p>数据宝统计显示，下周将要解禁的这64只股票，4月以来股价平均下跌18.35%，跑输沪指。仅有<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS603639" code="603639">海利尔</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS600901" code="600901">江苏租赁</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=NEEQ872925" code="872925">锦好医疗</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS600325" code="600325">华发股份</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS601611" code="601611">中国核建</a>的涨跌幅累计录得正值。<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ300988" code="300988">津荣天宇</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS600906" code="600906">财达证券</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS688355" code="688355">明志科技</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ000835" code="000835">长动退</a>等8股的股价跌幅居前，均下跌超30%。</p><p>根据一季报业绩来看，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS600809" code="600809">山西汾酒</a>的盈利最高，一季度实现营业收入105.3亿元，同比增长43.62%；净利润37.1亿元，同比增长70.03%。报告期内，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS600809" code="600809">山西汾酒</a>在南方市场销售平均增幅达60%以上。<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ300769" code="300769">德方纳米</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ002821" code="002821">凯莱英</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS688107" code="688107">安路科技</a>-U、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ300568" code="300568">星源材质</a>的2022年第一季度业绩同比翻倍上涨。相比之下，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS688655" code="688655">迅捷兴</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ002361" code="002361">神剑股份</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SZ002835" code="002835">同为股份</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS600841" code="600841">动力新科</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="https://info.stcn.com/dc/stock/?stockcode=SS603385" code="603385">惠达卫浴</a>的业绩同比下降幅度均超70%。（数据宝 郭洁）</p><p style="text-align: center;"><img src="https://data.stcn.com/djsj/202205/W020220507289701932367.png" title="WechatIMG663.png" alt="WechatIMG663.png" width="500px" height="1261.1902339776195px" style="width: 500px; height: 1261.19px;" oldsrc="W020220507289701932367.png" referrerpolicy="no-referrer"></p><p>声明：数据宝所有资讯内容不构成投资建议，股市有风险，投资需谨慎。</p>
  
</div>
            